Equities not available in your region
NBIX icon

Neurocrine Biosciences (NBIX)

NASDAQ

$152.30

$6.88 (

+4.73%

)

1D
5D
1M
6M
1Y
5Y
Market closed

NBIX: $152.30 / ₿ 0.002 BTC / 198199 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$145.43
$122.14 - $186.12
$1.55KCr
36.34
$1.00
10.16Cr
21.36
$149.25 - $160.00
Yes

The Neurocrine Biosciences (NBIX) stock price has been rising

The Neurocrine Biosciences, Inc. Common Stock (NBIX) stock price today is $152.30, reflecting a +4.73% move since the market opened. The company’s market capitalization stands at $1.55KCr, with a daily trading volume of $1.00 shares. The previous closing price was $145.43.

USD icon
USD
NBIX icon
NBIX

Only available to USA clients through the Kraken app
or Kraken Pro.

How to buy Neurocrine Biosciences stock on Kraken

Follow these three simple steps to buy shares of Neurocrine Biosciences stock on Kraken. Create your Kraken account in moments and connect your preferred funding method to buy stocks including NBIX. Kraken offers an easy, secure and licensed way to get started.

Options trade light dark

Step 1: Sign up

Provide your email address and country of residence* to create an account and get started with our secure verification process.

Deposit funds

Step 2: Choose a payment method

Send a bank wire, make an ACH purchase, use a debit card or choose from several other payment methods.

Create an account

Step 3: Buy Neurocrine Biosciences

Select “Buy stocks” on either Kraken’s web or mobile app and search for your desired stock to start your purchase.

Why buy Neurocrine Biosciences stocks with Kraken?

Kraken offers a secure and intuitive to buy 11,000+ US listed stocks and ETF stocks in the US, as well as tokenized xStocks for certain regions outside of the US. Use Kraken’s flexible payment methods to buy Neurocrine Biosciences stocks with a debit card, bank transfer or other payment option.

Flexible funding options

Enjoy fast and flexible funding options

Transactions are instant

Buy and sell 11,000+ stocks, ETFs and commodities

Kraken level security

Keep your portfolio secure with Passkeys

What is Neurocrine Biosciences (NBIX)?

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Learn more before buying Neurocrine Biosciences stock

NBIX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

NBIX is in the Drug Manufacturers - Specialty & Generic industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Neurocrine Biosciences, Inc. Common Stock (NBIX) has traded between a low of $122.14 and a high of $186.12.

NBIX is in the Drug Manufacturers industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Yes. Kraken offers a secure, highly liquid and intuitive way to buy 11,000+ stocks, ETFs and commodities. With advanced trading tools built for both indvidual investors and professional institutions, Kraken offers an all-in-one way to invest in cryptocurrencies, stocks, ETFs and the most important assets for your financial future.

The first step for new invstors looking to buy stocks is to a secure, reputable and competitive stock trading platform such as Kraken. After opening and funding your account. From there, it can be helpful to first research Neurocrine Biosciences and its recent market performance, From there, Kraken makes it easy to buy fractional shares of Neurocrine Biosciences so you can start small and build your portfolio over time.

Yes. Kraken’s mobile app allows you to buy, sell, and manage Neurocrine Biosciences trades on the go from your smartphone.

Earnings reports, product launches, economic data, sector performance, and broad market conditions all influence the price movement of Neurocrine Biosciences stock.

No. Kraken makes it easy to buy fractional shares of Neurocrine Biosciences, meaning you do not need to purchase a full share in order to add Neurocrine Biosciences to your portfolio.

Explore 11,000+ stocks, ETF and commodities

Buy Neurocrine Biosciences and thousands of popular stocks, ETFs or commodities available on Kraken today (geo restrictions apply).

Most active

Explore the most-traded stocks today

CYBL icon

CYBL

TCEHY icon
PRPH icon

Top gainers

Browse today’s biggest stock market winners

MSPR icon
SONDQ icon
LKCOF icon
CREG icon

Top losers

Compare the worst-performing stocks of 
the day

Want to learn more about equities?

Check out our Kraken Learn Center guides

General stock risks

Investing in stocks is risky and each stock can have its own set of risks. Below is a list of risks that generally apply to all stocks:

Volatility: The performance of stocks can be volatile, with their value dropping as quickly as it can rise. You should be prepared to lose all the money you invest in stocks.

Liquidity: Some stocks may suffer from low liquidity which could prevent you buying or selling them at the price you want or expect.

Complexity: Specific stocks and ETFs may carry with them specific complex risks that are hard to understand. Do your own research and if something sounds too good to be true, it probably is.

Don’t put all your eggs in one basket: Putting all your money into a single type of investment is risky. Spreading your money across different investments makes you less dependent on any one to do well.

If you want to learn more about specific risks related to equity securities, please visit our dedicated equities disclosure page.

Want to invest in Neurocrine Biosciences? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.